Narcotic Antagonists in Schizophrenia: A Methodological Review

Herbal Medicine in the Treatment of Schizophrenia: A Review

As a chronic psychiatric disorder, schizophrenia affects the worldwide population with a lifetime prevalence of 1% and considerable long-term mortality, morbidity, and burden. Besides the adverse effects of routine treatment regimens, a significant portion of patients remain symptomatic despite treatment, especially those with negative symptoms which are the major disabling factors in these pat...

Narcotic Antagonists: The Search for Long-Acting Preparations, 4

S 7 DEVELOPMENT OF POLYLACTIC/GLYCOLIC ACID DELIVERY SYSTEMS FOR USE IN TREATMENT OF NARCOTIC ADDICTION A.D. Schwope, D.L. Wise, J.F. Howes 13 DEVELOPMENT OF INJECTABLE MICROCAPSULES FOR USE IN THE TREATMENT OF NARCOTIC ADDICTION C. Thies 19 LONG-ACTING NARCOTIC ANTAGONIST COMPLEXES A.P. Gray, W.J. Guardina 21 SUSTAINED RELEASE OF NALTREXONE FROM GLYCERIDE IMPLANTS M.F. Sullivan, D.R. Kalkwarf ...

Narcotic antagonists: naltrexone pharmacochemistry and sustained-release preparations.

GABA abnormalities in schizophrenia: a methodological review of in vivo studies.

Abnormalities of GABAergic interneurons are some of the most consistent findings from post-mortem studies of schizophrenia. However, linking these molecular deficits with in vivo observations in patients - a critical goal in order to evaluate interventions that would target GABAergic deficits - presents a challenge. Explanatory models have been developed based on animal work and the emerging ex...

Suicide in Narcotic Drugs Dependents

Background: The problem of addiction is one of the four global crises. These patients are more vulnerable to mental disorders. This study aimed to examine the risk of suicide in drug dependent patients. Methods: In this cross-sectional study, patients who referred for addiction treatment were selected and the control group was chosen among their companions who did not have narcotic drugs depend...